Ameritas Investment Partners’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.5K | Hold |
2,887
| – | – | ﹤0.01% | 2351 |
|
|
2025
Q1 | $29.4K | Hold |
2,887
| – | – | ﹤0.01% | 2388 |
|
|
2024
Q4 | $45.7K | Hold |
2,887
| – | – | ﹤0.01% | 2238 |
|
|
2024
Q3 | $168K | Hold |
2,887
| – | – | 0.01% | 1438 |
|
|
2024
Q2 | $132K | Buy |
2,887
+327
| +13% | +$14.9K | ﹤0.01% | 1552 |
|
|
2024
Q1 | $169K | Buy |
2,560
+324
| +14% | +$21.4K | 0.01% | 1403 |
|
|
2023
Q4 | $88.9K | Hold |
2,236
| – | – | ﹤0.01% | 1818 |
|
|
2023
Q3 | $71.3K | Buy |
2,236
+377
| +20% | +$12K | ﹤0.01% | 1878 |
|
|
2023
Q2 | $74.7K | Buy |
1,859
+448
| +32% | +$18K | ﹤0.01% | 1789 |
|
|
2023
Q1 | $60.3K | Hold |
1,411
| – | – | ﹤0.01% | 1855 |
|
|
2022
Q4 | $72.5K | Hold |
1,411
| – | – | ﹤0.01% | 1815 |
|
|
2022
Q3 | $53K | Buy |
1,411
+319
| +29% | +$12K | ﹤0.01% | 1938 |
|
|
2022
Q2 | $30K | Hold |
1,092
| – | – | ﹤0.01% | 2316 |
|
|
2022
Q1 | $59K | Hold |
1,092
| – | – | ﹤0.01% | 1962 |
|
|
2021
Q4 | $64K | Hold |
1,092
| – | – | ﹤0.01% | 1981 |
|
|
2021
Q3 | $43K | Hold |
1,092
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q2 | $46K | Hold |
1,092
| – | – | ﹤0.01% | 2244 |
|
|
2021
Q1 | $67K | Hold |
1,092
| – | – | ﹤0.01% | 1905 |
|
|
2020
Q4 | $77K | Buy |
1,092
+477
| +78% | +$33.6K | ﹤0.01% | 1716 |
|
|
2020
Q3 | $24K | Hold |
615
| – | – | ﹤0.01% | 2286 |
|
|
2020
Q2 | $23K | Buy |
+615
| New | +$23K | ﹤0.01% | 2292 |
|